Pharming Group NV
AEX:PHARM

Watchlist Manager
Pharming Group NV Logo
Pharming Group NV
AEX:PHARM
Watchlist
Price: 1.7 EUR 0.59%
Market Cap: €1.2B

Intrinsic Value

The intrinsic value of one PHARM stock under the Base Case scenario is 1.2 EUR. Compared to the current market price of 1.7 EUR, Pharming Group NV is Overvalued by 30%.

PHARM Intrinsic Value
1.2 EUR
Overvaluation 30%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Pharming Group NV

What is Valuation History?
Ask AI Assistant
What other research platforms think about PHARM?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is PHARM valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Pharming Group NV.

Explain Valuation
Compare PHARM to
Custom
Choose any stock to compare

Fundamental Analysis

PHARM Profitability Score
Profitability Due Diligence

Loading...
Loading...
Loading...
Loading...
Profitability
Score

PHARM Solvency Score
Solvency Due Diligence

Loading...
Loading...
Loading...
Loading...
Solvency
Score
Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about PHARM?
Bearish
Neutral
Bullish
Efficiency

Free Cash Flow Analysis
Pharming Group NV

Last Value
3-Years Average
FCF Margin
Conversion Rate

Wall St
Price Targets

PHARM Price Targets Summary
Pharming Group NV

Wall Street analysts forecast PHARM stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PHARM is 2.15 EUR with a low forecast of 1.82 EUR and a high forecast of 2.57 EUR.

Lowest
Price Target
1.82 EUR
7% Upside
Average
Price Target
2.15 EUR
27% Upside
Highest
Price Target
2.57 EUR
51% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Pharming Group NV
does not pay dividends
Shareholder Yield

Current shareholder yield for PHARM is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one PHARM stock?

The intrinsic value of one PHARM stock under the Base Case scenario is 1.2 EUR.

Is PHARM stock undervalued or overvalued?

Compared to the current market price of 1.7 EUR, Pharming Group NV is Overvalued by 30%.

Back to Top